Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
Adcendo ApS Completes $75 Million Series C Financing to Continue Advancing First- and Best-in-class Clinical ADC Pipeline
14 Apr 2026
PR Newswire Association LLC.
triSure NIPT Debuts in Taiwan, Expanding Non-Invasive Prenatal Screening Beyond Aneuploidy
14 Apr 2026
GlobeNewswire
Asgard Therapeutics appoints Professor Dr Wolfram Brugger as Chief Medical Officer as it advances transformative ‘personalized off-the-shelf’ immunotherapy toward clinical development
14 Apr 2026
GlobeNewswire
Novo Nordisk and OpenAI partner to transform how medicines are discovered and delivered
14 Apr 2026
PR Newswire Association LLC.
Lundbeck to showcase new neurology data at the American Academy of Neurology Annual Meeting
13 Apr 2026
GlobeNewswire
Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian Cancer
13 Apr 2026
GlobeNewswire
Boehringer Ingelheim introduces LENZELTA®: A new vaccine advancing mastitis prevention in dairy cows
13 Apr 2026
PR Newswire Association LLC.
Photocure ASA: Update on Regulatory Classification for OAY Equipment
13 Apr 2026
PR Newswire Association LLC.
Sirtex Medical's DOORwaY90 Study Demonstrates 100% Local Tumor Control with SIR-Spheres®, Setting a New Benchmark in Y-90 for HCC
13 Apr 2026
PR Newswire Association LLC.
Hexagon to acquire Waygate Technologies, expanding into non-destructive testing
13 Apr 2026
GlobeNewswire
Orion publishes Interim Report for January–March 2026 and holds a webcast on 23 April 2026
10 Apr 2026
PR Newswire Association LLC.
DeepCyte Raises $1.5M to Bring Single-Cell AI Toxicology to Drug Development
09 Apr 2026
PR Newswire Association LLC.
GTCR Completes Acquisition of Zentiva, a Leading European Generics Pharmaceutical Company
09 Apr 2026
GlobeNewswire
Ecuador Free of Rabies project accelerates progress toward eliminating dog-mediated rabies supported by Boehringer Ingelheim’s Stop Rabies program
09 Apr 2026
GlobeNewswire
Novo Nordisk A/S: Wegovy® injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU
09 Apr 2026
GlobeNewswire
Boehringer Ingelheim to evaluate innovative combination of DLL3‑targeting T‑cell engager plus PD‑L1/VEGF‑A bispecific antibody in small cell lung cancer
09 Apr 2026
GlobeNewswire
Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030
09 Apr 2026
GlobeNewswire
Sobi Receives Health Canada Approval for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
09 Apr 2026
GlobeNewswire
Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson
09 Apr 2026
PR Newswire Association LLC.
Invitation to Vitrolife Group's presentation of the Q1 2026 interim report
09 Apr 2026
GlobeNewswire
Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference
08 Apr 2026
PR Newswire Association LLC.
SciBase reaches milestone with over 400,000 tests sold with Nevisense
07 Apr 2026
PR Newswire Association LLC.
Wegovy® pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026
02 Apr 2026
PR Newswire Association LLC.
NUHS CHARTS NEW ERA OF PERSONALISED CARE WITH GENOMICS AND DATA-GUIDED BREAKTHROUGHS
02 Apr 2026
PR Newswire Association LLC.
Bioretec Ltd publishes an exemption document relating to its rights issue
02 Apr 2026
Upcoming Events All Events
- April 2026
- BioTrinity 2026
- Oslo: 7th Norwegian Life Science Investor Partnering Day
- Seattle: Life Science Innovation Northwest 2026